# Kieran Mudryy

> Kieran Mudryy is a Series B investor at 4BIO Capital backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [4BIO Capital](https://shizune.co/investors/profile/4bio-capital-partners)
- Location: London, United Kingdom
- Total investments: 1
- Last investment: Jun 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kieran-mudryy-71991756/

Kieran Mudryy is a Series B investor at 4BIO Capital in London focused on Health Care and Biotechnology. Kieran Mudryy is the Partner at 4BIO Capital. Kieran Mudryy attended College of Law, Guildford, UK.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LUCA Science | LUCA Science develops innovative treatments intended for mitochondrial and related diseases. | $29.2M | Series B | Jun 06, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 2 deals together
- [Nippon Venture Capital](https://shizune.co/investors/profile/nippon-venture-capital) — VC Fund, 2 deals together
- [Asahi Kasei Pharma](https://shizune.co/investors/profile/asahi-kasei-pharma) — VC Fund, 1 deal together
- [DCI Partners](https://shizune.co/investors/profile/dci-partners) — VC Fund, 1 deal together
- [NCB Ventures](https://shizune.co/investors/profile/ncb-ventures) — VC Fund, 1 deal together
- [Nissay Capital](https://shizune.co/investors/profile/nissay-capital) — VC Fund, 1 deal together

## About 4BIO Capital

VC Fund · London, United Kingdom

4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech -biologics, gene and cell therapy and bioinformatics.

5 contacts available at 4BIO Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Kozlov | Managing Partner | https://shizune.co/investors/profile/andrey-kozlov |
| Dmitry Kuzmin | Managing Partner | https://shizune.co/investors/profile/dmitry-kuzmin |
| Kieran Mudryy | Partner | https://shizune.co/investors/profile/kieran-mudryy |
| Owen Smith | Principal | https://shizune.co/investors/profile/owen-smith-b474 |
| Vasily Fedorin | Principal | https://shizune.co/investors/profile/vasily-fedorin |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Kieran Mudryy invest in?

Kieran Mudryy invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kieran Mudryy last invest?

The most recent investment recorded for Kieran Mudryy closed in Jun 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co